Montreal-based Knight Therapeutics has galloped in with CAD $120 million ($84 million) to pick up Endo’s Paladin Pharma unit ...

Through a clear blue sky, 3rd Infantry Division units rained steel and explosives on Fort Stewart’s impact area earlier this ...

MONTREAL, March 11, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-US) specialty pharmaceutical company, announced today that it has entered into a ...

USA-based Endo Inc (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its international ...

Knight will pay $120-million cash to seller Endo Operations as well as future contingency payments of up to US$15-million ...

The couple was gunned down early Sunday near their home at the Paladin Club condominiums, off Edgemoor Road. New Castle ...

Knight Therapeutics has agreed to acquire generics and specialty branded pharmaceutical company Paladin Pharma for 120 million Canadian dollars ($83.1 million).

Endo Inc. said Tuesday it has entered into an agreement to divest its international pharmaceuticals business to Knight ...

Significantly high institutional ownership implies Paladin Energy's stock price is sensitive to their trading actions. 50% of the business is held by the top 8 share ...

In a report released today, Matthew Hope from Ord Minnett upgraded Paladin Energy Ltd (PALAF – Research Report) to a Buy, with a price target ...